Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Regulatory News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further Distribution Agreement - PIFA Heparin/PF4

12 Aug 2010 07:00

RNS Number : 9463Q
Akers Biosciences, Inc.
12 August 2010
 



Embargoed: 0700hrs, 12 August 2010

 

Akers Biosciences, Inc.

("ABI" or the "Company")

 

Major PIFA Heparin/PF4 Contract

 

Akers Biosciences, Inc. (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce that the Company's PIFA Heparin/PF4 Rapid Assay has been added to the HealthTrust Purchasing Group (HPG) laboratory distribution contract.

 

HealthTrust Purchasing Group (HPG) is one of the leading Group Purchasing Organizations, supporting nearly 1,400 not-for-profit and for-profit acute care hospitals, including Hospital Corporation of America (HCA). HCA owns and operates over 160 hospitals and approximately 105 freestanding surgery centers in 20 US States and the United Kingdom. Other HPG members include a number of premier operators of US-based, acute care hospitals including Community Health Systems, Health Management Associates and Lifepoint.

ABI's President and CEO Thomas A. Nicolette commented:

"We were thrilled to get confirmation of HPG's addition of the PIFA Heparin/PF4 Rapid Assay to its laboratory products contract. PIFA's inclusion was spurred by demand from its member hospitals and we have already shipped orders. We have always been impressed with HPG's commitment to quality patient care and expertise in assessing value-oriented clinical products. We are confident that HPG's member hospitals will continue to find PIFA's time- and cost-saving benefits helpful in the clinical assessment of Heparin-Induced Thrombocytopenia."

 

 

Enquiries:

 

Thomas A. Nicolette

President and CEO

Tel. +1 856 848 8698

Ben Simons

M: Communications

Tel. +44 (0)20 7920 2340

 

Emma Earl

Daniel Stewart & Co.

Tel. +44 (0)20 7776 6550

 

  

 

About Akers Biosciences, Inc.

 

Akers Biosciences develops, manufactures, and supplies rapid, point of care screening and testing products designed to bring healthcare information both rapidly and directly to the consumer or healthcare provider. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. ABI has aligned with major healthcare companies and high volume medical products distributors to maximize product offerings, and to be a major worldwide competitor in diagnostics. Additional information on the Company and it products can be found at www.akersbiosciences.com.

 

 

About HealthTrust

HealthTrust Purchasing Group is a healthcare group purchasing organization. Established in May 1999, HPG's membership has tripled since its inception and the company supports over 1,400 not-for-profit and for-profit acute care hospitals, including HCA, Health Management Associates, Community Health Systems and Lifepoint, as well as over 3,000 ambulatory surgery centers, alternate care sites and physician practices. Annual purchasing volume is more than $14 billion with double-digit annual percentage growth expected. For more information, visit www.healthtrustcorp.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTBRGDISSBBGGB
Date   Source Headline
10th Dec 201210:39 amRNSNotice of AGM
26th Nov 20127:00 amRNSDistribution Partnership Forged in China
22nd Oct 20127:00 amRNSIssue of Equity
8th Oct 201212:00 pmRNSHolding(s) in Company
17th Sep 20127:00 amRNSPrivate Placing
17th Sep 20127:00 amRNSHalf Yearly Report
28th Jun 20127:00 amRNSFinal Results
30th Mar 201210:06 amRNSHolding(s) in Company
27th Feb 20125:01 pmRNSDirectorate Change
6th Jan 20127:00 amRNSTrading Update
6th Dec 20117:00 amRNSLaunch of PIFA PLUSS PF4 Rapid Assay
7th Sep 20117:00 amRNSHalf Yearly Report
24th Aug 20117:00 amRNSClinical Trials Commenced: COPD Rapid Assay
30th Jun 20117:00 amRNSUS$3.2 Million Purchase Order for Revelar
10th May 20115:54 pmRNSResult of AGM
28th Apr 20113:41 pmRNSAnnual Report & Accounts & AGM Notice
27th Apr 20117:00 amRNSUS patent protection grant
18th Apr 20117:00 amRNSAsthma Breath Test - Clinical Trials
11th Apr 20117:02 amRNSFinal Results
11th Apr 20117:00 amRNSSupply Agreement & Technology Acquisition
8th Apr 20117:00 amRNSConclusion of HIT Study
16th Mar 20117:00 amRNSPatent Protection - Rapid Blood Cell Separator
2nd Mar 20114:20 pmRNSHolding(s) in Company
28th Feb 20117:00 amRNSTotal Voting Rights
14th Feb 20113:08 pmRNSTR-1 Notification of Major Interest in Shares
14th Feb 20112:57 pmRNSTR-1 Notification of Major Interest in Shares
10th Feb 20117:00 amRNSIssue of Equity & Director Shareholding
1st Feb 20117:00 amRNSPlacing
14th Jan 20117:00 amRNSBreathScan PRO Receives Regulatory Clearance
5th Jan 20117:00 amRNSTrading Statement
29th Dec 20107:00 amRNSOrder for Tri-Cholesterol Tests - Middle East
16th Nov 20101:14 pmRNSIssue of Equity
30th Sep 20103:57 pmRNSHalf Yearly Report
29th Sep 20107:00 amRNSPIFA Heparin/Platelet Factor-4 - New Data
6th Sep 20107:00 amRNSProduct Distribution Expansion: Middle East/India
12th Aug 20107:00 amRNSFurther Distribution Agreement - PIFA Heparin/PF4
21st Jul 20105:18 pmRNSResult of AGM
21st Jun 20107:00 amRNSFinal Results
18th Jun 20107:00 amRNSBreath Ketone Test - Positive Data
14th Jun 20107:00 amRNSUSA Distribution Agreement
9th Jun 20107:00 amRNSBreathScan Alcohol Detection - Product Extension
26th Mar 20104:52 pmRNSHolding(s) in Company
19th Mar 20101:00 pmRNSChange of Adviser
17th Mar 20107:00 amRNSBreathScan Licensing Agreement - UK & Ireland
16th Mar 20107:00 amRNSClinical Study Data - PIFA Heparin
18th Feb 20109:04 amRNSDirector/PDMR Shareholding
30th Dec 20097:00 amRNSDirectorate Change
17th Dec 20099:23 amRNSHolding(s) in Company
15th Dec 20097:00 amRNSABI Obtains GSA Contract
4th Dec 20097:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.